Liver Transplantation

Article	Citations
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	93
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	53
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	52
Issue Information ‐ Instructions to Authors	45
Making the best use of testing for blood phosphatidylethanol	43
Issue Information ‐ Author Checklist	42
Reply	39
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	39
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	39
Gastrointestinal Infection and Liver Injury Are the Risk Factors for Coronavirus Disease 2019 Inpatients With Assisted Ventilation	39
Deceased donor selection and management	38
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	35
Issue Information	34
Three Problems, Two Viruses, and One Man with a Vision and Voice: Larry Kramer, Medical Activist	34
Issue Information ‐ Instructions to Authors	34
Introducing the Certificate of Added Qualification (CAQ) Corner	34
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	33
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	32
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	32
Issue Information	31
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	30
Acute liver failure: Do we have a consensus regarding management?	30
Coronavirus Disease 2019 and Liver Transplantation: Lessons from the First Year of the Pandemic	30
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	29
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	29

Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	28
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	27
Incidence and risk factors for chronic rejection in pediatric liver transplantation	27
Semaglutide is effective in achieving weight loss in liver transplant recipients	25
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	25
Leveraging a Machine‐Learning Approach to Predict Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A Step in the Right Direction?	24
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	24
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	24
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A non-invasive approach	24
Issue Information ‐ Author Checklist	24
Low Levels of Hepatocyte‐Specific Methylation in Cell‐Free DNA Are a Strong Negative Predictor for Acute T Cell–Mediated Rejection Requiring Treatment Following Liver Transplantation	24
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	23
When worlds collide	23
Issue Information	23
Issue Information	23
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	23
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	23
Erratum	22
Bariatric surgery post-liver transplantation: A Belgian nationwide study	22
Those Donor Leucocytes Again? This Time It’s VITT!	22
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	22
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	21
Operational tolerance is not always permanent	21
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: Creating a Multidisciplinary Team Greater Than the Sum of Its Parts?	21
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	21
Demarcating the Exact Midplane of the Liver Using Indocyanine Green Near‐Infrared Fluorescence Imaging During Laparoscopic Donor Hepatectomy	21
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	21
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	20
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	20
Issue Information ‐ Author Checklist	20
PRO: All patients should receive a palliative care consult during LT evaluation	20
Deceased Donor Liver Transplantation from a SARS‐CoV‐2–Positive Donor to a SARS‐CoV‐2–Positive Recipient	20
PRO: Is the management of ACLF better in a liver-dedicated ICU?	20
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	20
Remembrance of a Passing Pandemic	20
Policy Corner: HCC exception update	20
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	20
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	19
Liver transplantation for pediatric liver malignancies	19
Extensive Health Care Utilization and Costs of an Early Liver Transplantation Program for Alcoholic Hepatitis	19
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	19
Long‐term quality of life of living liver donors: A Japanese nationwide survey	18
The Role of Psychosocial Screening Tools in the Evaluation of Transplantation Patients With Alcohol‐Related Liver Disease	18
Procurement Liver Biopsies: More Scrutiny May Yield More Opportunities	18
A survey of national practice patterns of hepatocellular carcinoma surveillance for patients with fontan-associated liver disease: A call to action	18
Issue Information ‐ Author Checklist	18
Issue Information	18
Issue Information ‐ Instructions to Authors	18
Outcomes using steatotic liver grafts: Will machines score the final goal?	18
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	18

Effect of Acuity Circles Allocation Policy on Local Use of Donation After Circulatory Death Donor Livers	18
The 6‐Minute Walk Test Distance Predicts Mortality in Cirrhosis: A Cohort of 694 Patients Awaiting Liver Transplantation	18
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	17
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand	17
Navigating the road to liver transplantation equity	17
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	17
The Future of Quality Improvement for Cirrhosis	17
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	16
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	16
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	16
	16
Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	16
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	16
Decompensated cirrhosis but low MELD – should we wait or refer for liver transplantation?	16
PRO AI: AI-augmented allocation is in our future — We should invest the necessary resources today	16
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	16
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	15
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	15
Priority for kidney after liver transplantation: A safety net for all?	15
Issue Information	15
Looking for literal improvement in liver transplant outcomes	15
Trends and Health Care Outcomes Among Living Liver Donors: Are We Ready to Expand the Donor Pool With Living Liver Donations?	15
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	15
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	15
Reply	15
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	14
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	14
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease	14
Issue Information	14
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	14
A new tool to predict future liver allograft dysfunction?	14
	14
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	14
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	14
Reply: ChatGPT and unknown clinical questions about liver transplantation	14
Management of portal vein thrombosis in liver transplant candidates	14
Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients	13
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	13
Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis	13
Building a better mouse trap in liver retransplantation risk prediction: Is resoft the end or the beginning?	13
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	13
Issue Information	13
No Salvation Without Regeneration	13
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	13
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay	13
A New Hope for a New Year	13
Blood Pressure Variability Early After Liver Transplantation Predicts Long‐Term Mortality	13
Bacterascites confers poor patient prognosis beyond MELD prediction	12
Policy Corner: Polycystic liver disease MELD exception update	12
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	12
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study	12
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	12
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	12
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	12
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	12
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	12
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	12
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	12
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	12
Metabolic Complications in Liver Transplantation Recipients: How We Can Optimize Long‐Term Survival	12
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	11
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	11
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	11
Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?	11
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	11
No transplant candidate left behind	11
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	11
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	11
Excellent Outcome in Living Donor Liver Transplantation: Treating Patients With Acute‐on‐Chronic Liver Failure	11
Informatics-driven solutions for optimal care delivery in liver transplantation	11
Living Donor Liver Transplantation for Patients With Hepatocellular Carcinoma: What Are the Optimal Criteria?	11
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	11
Issue Information	10
Anticancer Effect of Statins in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma	10
Incidence and outcomes of liver retransplantation using living donor allografts in the US	10
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	10
Declining a Split‐Liver Offer Can Be Hazardous to Your Health	10
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	10
Language Accessibility of Liver Transplantation Center Websites	10
Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	10

Financial burden of cirrhosis is significantly reduced after liver transplantation	10
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	10
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	10
Reply	10
The impact of alcohol-associated liver disease on famous athletes who received Liver Transplants	9
Reduction of hepatectomy times in dutch organ procurement teams	9
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	9
Allograft Fibrosis After Pediatric Liver Transplantation: Incidence, Risk Factors, and Evolution	9
The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change	9
Erratum	9
Policy Corner: Cholangitis exception update	9
Erratum	9
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	9
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	9
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	9
HATs Off to Clot Blockers: A Potential New Role for Statins After Transplantation	9
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	9
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours	9
Untangling the web of waitlist dropout in HCC	8
Measuring the Toll of Acute Illness–Derived Frailty in Decompensated Cirrhosis	8
Second thoughts about second opinions for liver transplantation	8
Pediatric Living Donor Liver Transplantation Outcomes—Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks?	8
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	8
Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation	8
Portopulmonary hypertension: May we agree to disagree?	8
Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	8
Issue Information ‐ Instructions to Authors	8
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	8
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	8
Reduced Discard Rates of Split Liver Grafts by Having a Combined Adult‐Pediatric LT Program	8
Barriers to liver transplant referral in safety net settings: A national provider survey	8
Does hepatectomy technique matter?	8
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	8
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	8
Issue Information ‐ Instructions to Authors	8
Issue Information	8
Reply	8
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta‐analysis	8
Speaking of the (Barely Legal) Elephant in the Room: Herbal or Dietary Supplement–Related Acute Liver Failure	8
Maximizing outcomes by donor-recipient age matching in liver transplantation	7
The Prognostic Utility of Intraoperative Allograft Vascular Inflow Measurements in Donation After Circulatory Death Liver Transplantation	7
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	7
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	7
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	7
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	7
The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure	7
Anonymous Nondirected Living Liver Donation: Has the Time Come to Formalize the Process?	7
Anonymity: What does it mean and why is it important to anonymous living liver donors?	7
Combination of Donor Anthropometrics With Recipient Imaging to Improve Matching in Liver Transplantation	7
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	7
“Winning the peace” against obesity in recipients of liver transplant	7
Quantitative methods for optimizing patient outcomes in liver transplantation	7
The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death	7
Offer Acceptance Patterns for Liver Donors Aged 70 and Older	7
Geospatial analysis of liver donation after death by drug intoxication	7
Erratum	7
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	7
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	7
Issue Information ‐ Instructions to Authors	7
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	7
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	7
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	7
Reply	6
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation — a survey of the International Liver Transplantation Society (ILTS)	6
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	6
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	6
Salvaging the fatty liver for transplant: is short duration NMP enough?	6
Liver transplantation in tight junction protein‐2 deficiency associated liver disease	6
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	6
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	6
Reply	6
Telemedicine in Hepatology: Current Applications and Future Directions	6
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	6
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	6
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	6
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	6
Issue Information	6
A Modified liver donor risk index for pediatric liver transplant recipients	6
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	6
Pregnancy Outcomes After Living Liver Donation: A Multi‐Institutional Study	6
Letter to the Editor: Induction therapy in pediatric liver transplants affects outcomes	6
Issue Information ‐ Author Checklist	6
Is stenting really necessary during primary angioplasty for portal vein stenosis after pediatric liver transplantation?	6
Development and Validation of a Model to Predict Long‐Term Survival After Liver Transplantation	5
Psychiatric diagnoses are common after liver transplantation and are associated with increased health care utilization and patient financial burden	5
Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant	5
A novel method using the level of mobility to predict mortality in patients admitted for decompensated cirrhosis: A prospective study	5
Minimally invasive living donor liver transplantation: the future is here	5
	5
Reply: Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States	5
Steroid‐Resistant Acute Cellular Rejection of the Liver After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccination	5
Lower Child Opportunity Index is associated with increased health care utilization following pediatric liver transplantation	5
Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of HCC before liver transplant	5
Prediction of portal venous pressure in living donor liver transplantation: A retrospective study	5